摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl 5-(8-(4-((1S,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenylamino)-[1, 2, 4]triazolo[1,5-a]pyrazin-5-yl)-1H-pyrazole-3-carboxylate | 1195065-39-4

中文名称
——
中文别名
——
英文名称
Ethyl 5-(8-(4-((1S,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenylamino)-[1, 2, 4]triazolo[1,5-a]pyrazin-5-yl)-1H-pyrazole-3-carboxylate
英文别名
Ethyl 5-(8-(4-((1S,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenylamino)-[1,2,4]triazolo[1,5-a]pyrazin-5-yl)-1H-pyrazole-3-carboxylate;ethyl 3-[8-[4-[(1S,4S)-5-propan-2-yl-2,5-diazabicyclo[2.2.1]heptan-2-yl]anilino]-[1,2,4]triazolo[1,5-a]pyrazin-5-yl]-1H-pyrazole-5-carboxylate
Ethyl 5-(8-(4-((1S,4S)-5-isopropyl-2,5-diazabicyclo[2.2.1]heptan-2-yl)phenylamino)-[1, 2, 4]triazolo[1,5-a]pyrazin-5-yl)-1H-pyrazole-3-carboxylate化学式
CAS
1195065-39-4
化学式
C25H29N9O2
mdl
——
分子量
487.564
InChiKey
SHRYVOOMJVWWAC-OALUTQOASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    36
  • 可旋转键数:
    8
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    117
  • 氢给体数:
    2
  • 氢受体数:
    9

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • US8012983B2
    申请人:——
    公开号:US8012983B2
    公开(公告)日:2011-09-06
  • [EN] FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES<br/>[FR] COMPOSÉS DE PYRAZINE FUSIONNÉE UTILES DANS LE TRAITEMENT DE MALADIES DÉGÉNÉRATIVES ET INFLAMMATOIRES
    申请人:GALAPAGOS NV
    公开号:WO2009135885A1
    公开(公告)日:2009-11-12
    Novel [1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: Formula (Ia) or Formula (Ib). The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non- limiting example, pain, inflammation, and others.
  • FUSED PYRAZINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES
    申请人:Andrews Martin James Inglis
    公开号:US20090286798A1
    公开(公告)日:2009-11-19
    Novel[1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
    揭示了具有以下表示的公式的新型[1.2.4]三唑并咪唑[1,2-a]吡嗪化合物:这些化合物可以制备为药物组合物,并可用于哺乳动物包括人类的预防和治疗多种疾病,包括但不限于疼痛、炎症等。
  • Substituted triazolopyrazines useful for the treatment of degenerative and inflammatory diseases
    申请人:Galapagos NV
    公开号:US08012983B2
    公开(公告)日:2011-09-06
    Novel [1.2.4]triazolo[1,5-a]pyrazine and imidazo[1,2-a]pyrazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, and others.
    本发明揭示了一种具有以下代表性公式的Novel [1.2.4]triazolo[1,5-a]pyrazine和imidazo[1,2-a]pyrazine化合物:这些化合物可以制备为药物组合物,可以用于预防和治疗哺乳动物包括人类的各种疾病,例如但不限于疼痛、炎症等。
查看更多